Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,502,959
+$7,590,819 QoQ
Shares Held
902,650
+705.5% QoQ
Ownership
0.547%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 263 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,646,694,420 across 216 Biotechnology names. NVAX ranks #60 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in NVAX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,502,959 | 902,650 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $912,140 | 112,057 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $986,044 | 146,733 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,558,084 | 179,710 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $110,872 | 17,599 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $284,774 | 44,427 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $183,022 | 22,764 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $236,900 | 18,757 | Shares | Other | 2024-11-14 | |
| 2021-12-31 | $225,049 | 1,573 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $6,088,838 | 28,679 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,575,131 | 41,780 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,563,658 | 40,926 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,149,225 | 47,524 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,874,124 | 22,485 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||